Conditional Inference for Secondary Outcomes Based on the Testing Result for the Primary Outcome in Clinical Trials
基于临床试验主要结局检验结果的次要结局条件推断AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要将选择后的条件推断用于临床试验平均处理效应区间,因果效应推断是其明确列出的应用对象。
基于临床试验主要结局检验结果的次要结局条件推断AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
In clinical trials, inferences on clinical outcomes are often made conditional on specific selective processes. For instance, only when a treatment demonstrates a significant effect on the primary outcome, further analysis is conducted to investigate its efficacy on selected secondary outcomes. Similarly, inferences may also depend on whether a trial is terminated early at interim stage. While conventional approaches primarily aim to control the family-wise error rate through multiplicity adjustments, they do not necessarily ensure the desired statistical property of the inference result, when the analysis is conducted according to a selective process. For example, the conditional coverage level of a regular confidence interval under a selective processes can be very different from its nominal level even after adjustment for multiple testing. In this paper, we argue that the validity of the inference procedure conditional on selective process is important in many applications. In addition, we propose to construct confidence intervals with correct conditional coverage probability by accounting for related selective process. Specifically, our approach involves a pivotal quantity constructed by inversing the cumulative distribution function of a truncated normal distribution induced by the selective process. Theoretical justification and comprehensive simulations illustrate the effectiveness of this method in realistic settings. We also apply our method to analyze data from the SPRINT, resulting in more conservative but conditionally valid confidence intervals for the average treatment effect than those originally published.